Armata Pharmaceuticals (ARMP) Preferred Stock Liabilities (2013 - 2016)

Armata Pharmaceuticals has reported Preferred Stock Liabilities for 4 years, with the latest figure at $91000.0 in Q1 2016.

• Quarterly Preferred Stock Liabilities fell 99.53% year-over-year to $91000.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $91000.0 (down 99.53% YoY) and the FY2015 annual result came in at $11.9 million, down 3.49% from the prior year.
• Preferred Stock Liabilities retreated to $91000.0 in Q1 2016 per ARMP's latest filing, from $11.9 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $46.3 million in Q1 2014 and troughed at $91000.0 in Q1 2016.
• A 4-year average of $15.0 million and a median of $12.1 million in 2014 frame the typical range for Preferred Stock Liabilities.
• The sharpest annual moves came in 2014 and 2016: Preferred Stock Liabilities soared 1642.57% in 2014, then tumbled 99.53% in 2016.
• Over 4 years, Preferred Stock Liabilities stood at $707000.0 in 2013, then jumped by 1642.57% to $12.3 million in 2014, then decreased by 3.49% to $11.9 million in 2015, then slumped by 99.23% to $91000.0 in 2016.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $91000.0, $11.9 million, and $2.1 million for Q1 2016, Q4 2015, and Q3 2015 respectively.